Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2009 September;51(3) > Panminerva Medica 2009 September;51(3):139-50

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

  PERITONEAL DIALYSIS


Panminerva Medica 2009 September;51(3):139-50

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Expanding criteria for peritoneal dialysis use

Palomar R., Arias M.

Department of Nephrology, Universitary Hospital Marqués de Valdecilla, Santander, Spain


PDF  


The end stage renal disease population is growing all around the world. Most of these patients will need any kind of renal replacement treatment: renal transplantation, hemodialysis or peritoneal dialysis. Treatment of renal failure is costly and many analyses demonstrate that home based dialysis is the cheapest. In spite of social, clinical and economical advantages of peritoneal dialysis (PD), it is an underutilized modality of renal treatment. Low incidence and prevalence of PD as a renal replacement therapy is still a truth. Many factors influence that scarce use; nowadays there are countries which are making changes in their health systems in an effort to enhance its use. The following review presents the current situation of the use of Peritoneal Dialysis, its costs, complications and possible improvements to enhance its use.

top of page

Publication History

Cite this article as

Corresponding author e-mail

nefpfm@humv.es